HLPVSPACB• 28 Days (Normalized)
HLP vs PACB (Hongli Group Inc. vs Pacific Biosciences of California Inc.)
Showing Closing Date Range from Sep 8 to Oct 6, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
HLP Performance $2.47
+77.06%
Hongli Group Inc.
Normalized Baseline0.00%
PACB Performance $2.87
+117.42%
Pacific Biosciences of California Inc.
Normalized Baseline0.00%
Alpha Spread Margin PACB LEADS
-40.36 pts
PACB outperforming by 40.36 percentage points
HLPPACB
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
HLP PACB
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | HLP Price | HLP Gain (%) | PACB Price | PACB Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 05, 2026 | $2.47 | +77.06% | $2.87 | +117.42% | -40.36% |
| Oct 02, 2026 | $2.55 | +82.80% | $2.54 | +92.42% | -9.62% |
| Oct 01, 2026 | $- | $2.51 | +90.15% | - | |
| Sep 30, 2026 | $- | $2.37 | +79.55% | - | |
| Sep 29, 2026 | $- | $1.83 | +38.64% | - | |
| Sep 28, 2026 | $2.39 | +71.33% | $1.71 | +29.55% | +41.78% |
| Sep 25, 2026 | $2.21 | +58.42% | $- | - | |
| Sep 24, 2026 | $2.20 | +57.71% | $1.46 | +10.23% | +47.48% |
| Sep 23, 2026 | $2.04 | +45.88% | $1.41 | +6.82% | +39.06% |
| Sep 22, 2026 | $2.00 | +43.37% | $- | - | |
| Sep 21, 2026 | $2.03 | +45.52% | $1.36 | +3.03% | +42.49% |
| Sep 18, 2026 | $2.02 | +44.80% | $1.37 | +3.79% | +41.01% |
| Sep 17, 2026 | $2.02 | +44.80% | $1.38 | +4.55% | +40.25% |
| Sep 16, 2026 | $2.07 | +48.39% | $1.34 | +1.52% | +46.87% |
| Sep 15, 2026 | $1.82 | +30.47% | $1.34 | +1.52% | +28.95% |
Page 1 of 2